Compounds > 3-n-methylspiperone
Page last updated: 2024-09-03

3-n-methylspiperone and 7-hydroxy-2-n,n-dipropylaminotetralin

3-n-methylspiperone has been researched along with 7-hydroxy-2-n,n-dipropylaminotetralin in 1 studies

Compound Research Comparison

Studies
(3-n-methylspiperone)		Trials
(3-n-methylspiperone)		Recent Studies (post-2010)
(3-n-methylspiperone)		Studies
(7-hydroxy-2-n,n-dipropylaminotetralin)		Trials
(7-hydroxy-2-n,n-dipropylaminotetralin)		Recent Studies (post-2010) (7-hydroxy-2-n,n-dipropylaminotetralin)
15567398029

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gonzalez, AM; Sibley, DR1

Other Studies

1 other study(ies) available for 3-n-methylspiperone and 7-hydroxy-2-n,n-dipropylaminotetralin

ArticleYear
[3H]7-OH-DPAT is capable of labeling dopamine D2 as well as D3 receptors.
    European journal of pharmacology, 1995, Jan-05, Volume: 272, Issue:1

    Topics: Animals; Binding, Competitive; Brain; CHO Cells; Cricetinae; Cricetulus; Dopamine Agonists; Guanine Nucleotides; Rats; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Spiperone; Tetrahydronaphthalenes

1995